賽隆藥業(002898.SZ)擬設立珠海賽隆國際 持股比例51%
格隆匯4月20日丨賽隆藥業(002898.SZ)公佈,為促進公司總部及研究院開發建設,公司和中信城開珠海投資有限公司(“中信城開”)簽訂了《總部項目合作協議》。《總部項目合作協議》約定公司與中信城開共同成立項目公司,其中公司持股比例為51%,中信城開以及中信城開或其關聯方另行設立的投資基金(“中信方”)持股比例為49%。
擬設立珠海賽隆國際投資有限公司,註冊資金:1000萬元人民幣;經營範圍:項目投資;商務信息諮詢;市場調查;以自有資金開展投資;房地產開發經營;房地產諮詢服務;自有房地產經營;物業管理;貨物及技術的進出口業務。
根據《總部項目合作協議》約定,成立的項目公司股東會會議由股東按照認繳出資比例行使表決權;但在中信方持有項目公司51%或以上的股權前,公司同意將項目公司2%的股權對應的表決權讓渡給中信方行使,前述表決權的讓渡是不可撤銷及不可變更的。
此次對外投資設立子公司,有利於公司總部及研究院項目的順利開發,促進規範化運作,符合公司的利益和發展需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.